Annexon, Inc. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| Love Douglas | PRESIDENT AND CEO | Sale | 5,782 | $5.54 | $32,032 | 196,121 | Feb 12, 2024 |
| Lew Jennifer | EVP & CHIEF FINANCIAL OFFICER | Sale | 1,809 | $5.54 | $10,022 | 45,651 | Feb 12, 2024 |
| Yednock Ted | EVP & CHIEF INNOVATION OFFICER | Sale | 1,810 | $5.54 | $10,027 | 36,075 | Feb 12, 2024 |
| Yednock Ted | EVP & Chief Innovation Officer | Sale | 1,057 | $3.84 | $4,059 | 37,885 | Dec 27, 2023 |
| Yednock Ted | EVP & Chief Innovation Officer | Option Exercise | 10,615 | $1.41 | $14,967 | 10,615 | Dec 27, 2023 |
| Satter Muneer A | — | Purchase | 350,000 | $2.88 | $1,008,000 | 7,406,024 | Dec 26, 2023 |
| Overdorf Michael | EVP & Chief Business Officer | Sale | 978 | $3.84 | $3,756 | 45,802 | Jul 11, 2023 |
| Lew Jennifer | EVP & Chief Financial Officer | Sale | 1,057 | $3.84 | $4,059 | 47,460 | Jul 11, 2023 |
| Bain Capital Life Sciences Investors, LLC | — | Purchase | 300,000 | $2.13 | $639,000 | 5,701,926 | May 25, 2023 |
| Overdorf Michael | EVP & Chief Business Officer | Award / Grant | 18,975 | — | — | 46,780 | Feb 16, 2023 |
| Lew Jennifer | EVP & Chief Financial Officer | Award / Grant | 18,975 | — | — | 48,517 | Feb 16, 2023 |
| Love Douglas | President & CEO | Sale | 6,571 | $5.87 | $38,572 | 197,646 | Feb 15, 2023 |
| Lew Jennifer | EVP & Chief Financial Officer | Sale | 1,742 | $6.31 | $10,992 | 29,708 | Feb 14, 2023 |
| Overdorf Michael | EVP & Chief Business Officer | Sale | 144 | $6.30 | $907 | 27,805 | Feb 13, 2023 |
| Satter Muneer A | — | Purchase | 2,647,058 | $6.80 | $17,999,994 | 7,056,024 | Feb 10, 2023 |
| Overdorf Michael | EVP & Chief Business Officer | Award / Grant | 9,375 | — | — | 21,875 | Jul 11, 2022 |
| Mattheakis Larry | EVP & Chief Scientific Officer | Award / Grant | 4,688 | — | — | 17,188 | Jul 11, 2022 |
| Mattheakis Larry | EVP & Chief Scientific Officer | Award / Grant | 4,688 | — | — | 17,188 | Jul 11, 2022 |
| Lew Jennifer | EVP & Chief Financial Officer | Award / Grant | 9,375 | — | — | 23,875 | Jul 11, 2022 |
| Satter Muneer A | — | Purchase | 2,453,988 | $3.84 | $9,423,314 | 4,408,966 | Jul 7, 2022 |
| Love Douglas | President & CEO | Purchase | 60,000 | $2.45 | $147,000 | 200,942 | Apr 14, 2022 |
| Love Douglas | President & CEO | Award / Grant | 40,000 | — | — | 140,942 | Feb 11, 2022 |
| Overdorf Michael | EVP & Chief Business Officer | Award / Grant | 12,500 | — | — | 12,500 | Feb 11, 2022 |
| Keswani Sanjay | EVP & Chief Medical Officer | Award / Grant | 12,500 | — | — | 12,500 | Feb 11, 2022 |
| Lew Jennifer | EVP & Chief Financial Officer | Award / Grant | 12,500 | — | — | 14,500 | Feb 11, 2022 |
| Mattheakis Larry | EVP & Chief Scientific Officer | Award / Grant | 12,500 | — | — | 12,500 | Feb 11, 2022 |
| Love Douglas | President & CEO | Option Exercise | 70,942 | $1.41 | $100,028 | 70,942 | Nov 11, 2021 |
| Love Douglas | President & CEO | Sale | 7,500 | $22.05 | $165,375 | — | Sep 16, 2021 |
| Yednock Ted | EVP & Chief Scientific Officer | Option Exercise | 15,000 | $1.41 | $21,150 | 15,000 | Sep 13, 2021 |
| Lew Jennifer | EVP & Chief Financial Officer | Option Exercise | 3,500 | $7.49 | $26,215 | 5,500 | Sep 13, 2021 |
| Love Douglas | President & CEO | Sale | 3,750 | $22.55 | $84,563 | — | Jun 7, 2021 |
| Yednock Ted | EVP & Chief Scientific Officer | Sale | 2,184 | $21.72 | $47,436 | — | Jun 3, 2021 |
| Lew Jennifer | EVP & Chief Financial Officer | Option Exercise | 3,500 | $7.49 | $26,215 | 5,500 | May 27, 2021 |
| Love Douglas | President & CEO | Sale | 300 | $28.01 | $8,403 | — | Apr 1, 2021 |
| Love Douglas | President & CEO | Sale | 300 | $27.24 | $8,172 | — | Mar 29, 2021 |
| Yednock Ted | EVP & Chief Scientific Officer | Sale | 5,680 | $29.21 | $165,913 | 237 | Mar 25, 2021 |
| Keswani Sanjay | EVP & Chief Medical Officer | Sale | 3,995 | $30.17 | $120,529 | — | Mar 24, 2021 |
| Lew Jennifer | EVP & Chief Financial Officer | Sale | 1,800 | $28.43 | $51,174 | 3,800 | Mar 23, 2021 |
| Clarus Lifesciences III, L.P. | — | Purchase | 200,000 | $17.00 | $3,400,000 | 2,730,635 | Jul 28, 2020 |
| Redmile Group, LLC | — | C | 1,596,222 | — | — | 1,596,222 | Jul 28, 2020 |
| Bain Capital Life Sciences Fund, L.P. | — | Purchase | 400,000 | $17.00 | $6,800,000 | 3,241,628 | Jul 28, 2020 |
| Lew Jennifer | EVP & Chief Financial Officer | Purchase | 2,000 | $17.00 | $34,000 | 2,000 | Jul 28, 2020 |
| Satter Muneer A | — | C | 1,754,978 | — | — | 1,754,978 | Jul 28, 2020 |
| DEERFIELD PARTNERS, L.P. | — | C | 458,914 | — | — | 458,914 | Jul 28, 2020 |